Reports
Reports
Sale
The global transfer membrane market size was valued at USD 494.5 million in 2023, driven by the increasing investment in drug development across the globe. The market is expected to grow at a CAGR of 4.4% during the forecast period of 2024-2032, with the values likely to rise to USD 725.8 million by 2032.
A transfer membrane is used in molecular biology and biochemistry techniques to transfer proteins, DNA, RNA, or other biological elements from a gel matrix to a solid support so that further detection and analysis may be performed. It is also known as a blotting membrane. Transfer membranes are available in different pore sizes, which may differ based on molecule being transferred. It can be made of nitrocellulose or PDVF, as they compatible with protein and nucleic acid bindings. The gel electrophoresis process plays a critical role in transfer membrane process.
After the COVID-19 outbreak, the demand for diagnostic tests has significantly increased. The rising investments to expediate drug and vaccine development has seen an upswing, accredited to high occurrence of genetic diseases. As a result, the transfer membrane market value has grown owing to its crucial involvement in the study of diseases, drug development as well as diagnostic tests.
The transfer membranes hold immense significance in pharmaceutical industry for protein purification and analysis. This has led to novel innovations, aimed at fostering quality outcomes. One such common example is the launch of Immobilon® NOW by Merck. This is a transfer membrane roll which allows features like single-cut convenience, minimal waste, compact packaging to save space in the research lab and compatibility with mini or midi gels.
As per research, it has been indicated that PVDF membrane type has more advantages over nitrocellulose. They are compatible with several detection chemistries including chemogenic, radioactive, fluorescent, and chemiluminescent techniques. Therefore, to meet the high demand, Merck has four different types of PVDF membranes under the Immobilon® membranes section. These membranes offer high protein binding and durability, which is set to cater to the high transfer membrane market demand in upcoming years.
Market Breakup by Type
Market Breakup by Transfer
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
North America, specifically the United States, has been dominating the transfer membrane market share. This considerable share may be accredited to the existence of a well-established research infrastructure and growing government investments in the pharmaceutical domain. Moreover, the presence of pioneer biotechnology and pharmaceutical companies, along with academic and research institutions also aid the growth of the market. Having a robust public healthcare system, Europe is second in line to lead the market share in forecast period.
Due to high population growth, government initiatives, and private investments, the Asia Pacific region is anticipated to achieve rapid transfer membrane market growth in the future. The governments are gradually prioritising the high importance of medical research and development and working towards developing a technically enhanced infrastructure for effective research work. Furthermore, the private sector is booming with the advent of foreign investment. Pharma and biotech giants have started establishing their headquarters in the Asia Pacific region to leverage the academic talent along with the easy availability of other resources.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Transfer |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Transfer Membrane Market Overview
3.1 Global Transfer Membrane Market Historical Value (2017-2023)
3.2 Global Transfer Membrane Market Forecast Value (2024-2032)
4 Global Transfer Membrane Market Landscape
4.1 Global Transfer Membrane Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Transfer Membrane Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Transfer
4.2.3 Analysis by Application
5 Global Transfer Membrane Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Transfer Membrane Market Segmentation
6.1 Global Transfer Membrane Market by Type
6.1.1 Market Overview
6.1.2 Nylon
6.1.3 Nitrocellulose
6.1.4 PVDF
6.2 Global Transfer Membrane Market by Transfer
6.2.1 Market Overview
6.2.2 Semi-dry Electrotransfer
6.2.3 Dry Electrotransfer
6.2.4 Tank Electrotransfer
6.3 Global Transfer Membrane Market by Application
6.3.1 Market Overview
6.3.2 Amino Acid and Protein Sequencing Analysis
6.3.3 Southern Blotting
6.3.4 Northern Blotting
6.3.5 Western Blotting
6.4 Global Transfer Membrane Market by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical and Biotechnology Companies
6.4.3 Diagnostic Laboratories
6.4.4 Academic and Research Institutes
6.4.5 Others
6.5 Global Transfer Membrane Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Transfer Membrane Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Transfer Membrane Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Transfer Membrane Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Transfer Membrane Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Transfer Membrane Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Thermo Fisher Scientific, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Danaher
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bio-Rad Laboratories
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Merck KGaA
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 PerkinElmer, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Abcam Plc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 ATTO Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Santa Cruz Biotechnology, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Azure Bio systems Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Advansta Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 GVS Filter TS.p.A.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 GE Healthcare
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Axiva Sichem Biotech
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Transfer Membrane Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 494.5 million in 2023, driven by increased investment in drug and vaccine development across the globe.
The market is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 725.8 million by 2032.
The increase in investments made by key players is fostering market demand.
The market is witnessing the emergence of new technologies for transfer membranes. Prominent companies are coming forward with latest inventions. One such example is the introduction of Immobilon® NOW by Merck. It is a transfer membrane roll which has the compatibility with mini or midi gels, leaves minimal waste and has compact packaging to save space in labs.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Common application areas include amino acid and protein sequencing analysis, southern blotting, northern blotting, and western blotting.
Nylon, PVDF, and nitrocellulose are some of the common types of transfer membranes.
It is divided into semi-dry electrotransfer, dry electrotransfer, and tank electrotransfer.
Major end users include pharmaceutical and biotechnology companies, diagnostic laboratories, academic and research institutes, and others.
Key players involved in the market are Thermo Fisher Scientific, Inc., Danaher, Bio-Rad Laboratories, Merck KGaA, PerkinElmer, Inc., Abcam Plc., ATTO Corporation, Santa Cruz Biotechnology, Inc., Azure Bio systems Inc., Advansta Inc., GVS S.p.A., GE Healthcare, and Axiva Sichem Biotech.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.